Clinical Trial Update: Atorvastatin Effect on Contrast Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating atorvastatin vs. outcomes for contrast-induced nephropathy in diabetic patients undergoing elective coronary intervention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Mohamed Abdelfatah | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED